Intravenous Lignocaine as an Analgesic Adjunct in Adolescent Idiopathic Scoliosis Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

115

Participants

Timeline

Start Date

December 24, 2020

Primary Completion Date

March 31, 2022

Study Completion Date

September 30, 2022

Conditions
Adolescent Idiopathic ScoliosisAnalgesia
Interventions
DRUG

Lignocaine

Group A will receive 1.5mg/kg IV lignocaine bolus prior to induction followed by 2mg/kg/hour of lignocaine infusion throughout surgery until wound closure in which the infusion will be halved to 1mg/kg/hour until the end of surgery. The same rate will be infused in the recovery room for another half an hour before participant is discharge.

DRUG

Normal saline

Group B will receive saline of similar volume and rate as Group A

Trial Locations (1)

59100

University Malaya, Pantai Valley

All Listed Sponsors
lead

University of Malaya

OTHER

NCT04931433 - Intravenous Lignocaine as an Analgesic Adjunct in Adolescent Idiopathic Scoliosis Surgery | Biotech Hunter | Biotech Hunter